Nexplanon:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DID2015API204)
◆英語タイトル:Nexplanon-API Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DID2015API204
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD1,000 ⇒換算¥113,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Nexplanon:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015]についてメールでお問い合わせはこちら
当調査レポートでは、Nexplanon医薬品市場について調査・分析し、医薬品の概要、世界販売量予測、作用機序、薬力学的特性、薬物動態学的特性、アメリカ及びヨーロッパでの市販状況、特許情報、世界各地域別APIメーカー分析情報などを以下の構成でお届けいたします。※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。

・医薬品の概要
・世界販売量予測データ
・医薬品の説明
・作用機序(MOA)
・薬力学的特性
・薬物動態学的特性
・市販状況:アメリカ、ヨーロッパ
・特許情報
・特許権及び独占権(Exclusivity)存続期間
・グローバルAPIメーカー:地域別分析
・企業概要
*** レポート概要(サマリー)***

Summary
DelveInsight’s, Nexplanon-API Insights, 2015,report provides Nexplanon marketed details and API Manufacturers details across the globe along with the location. DelveInsight’s report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Nexplanon. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the Nexplanon Global sales forecasts data till 2016.
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

[Data Sources]
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


Scope

• A review of the Nexplanon based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Nexplanon on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for drug with location details.
• Patent Expiry Timeline and Exclusivity Details
• Global Forecasted Sales Figure from 2012-2016
• Qualitative and quantitative assessment of market space


*** レポート目次(コンテンツ)***

Table of Contents

• Drug Overview
• Global Sales Assessment
• Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Marketed Details for the United States
• Marketed Details for the Europe
• Patent Information
• Patent and Exclusivity Expiry Assessment United States (US)
• Patent Numbers and Expiry Details
• Patent Details
• Global API Manufacturers Assessment
• The United States Drug Master File (US DMF)
• The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
• The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
• The Active Pharmaceutical Ingredient (API) Manufacturers by Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
• Generic Players
• Company Profile
• Summary
• Company Financials
• References
• Appendix
• Methodology
• About DelveInsight
• Contact Us
• Disclaimer

List of Tables
• Nexplanon, Market, Global Sales (in USD), 2015
• Nexplanon, Description
• Nexplanon, Marketed Details the United States (US)
• Nexplanon, Marketed Details the Europe (EU)
• Nexplanon, Patent/Exclusivity Expiry (Year), 2015
• Nexplanon, Patent Number Specific Patent Expiry (Year), 2015
• Nexplanon, Patent Details
• Nexplanon, the United States Drug Master File (US DMF), 2015
• Nexplanon, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2015
• Nexplanon, the API Manufacturers, China, 2015
• Nexplanon, the API Manufacturers, India, 2015
• Nexplanon, the API Manufacturers by the US DMF Status, 2015
• Nexplanon, the API Manufacturers by Region, 2015
• Nexplanon, the API Manufacturers by Location/Countries, 2015
• Nexplanon, Generic Players, 2015
• Company Overview, 2015

List of Figures
• Nexplanon, Market, Global Sales (in million USD), 2015
• Nexplanon, Global Sales % Change, 2015
• Nexplanon, Patent/Exclusivity Expiry (Year), 2015
• Nexplanon, Patent Number Specific Patent Expiry (Year), 2015
• Nexplanon, the API Manufacturers by the US DMF Status (%), 2015
• Nexplanon, the API Manufacturers by Region, 2015
• Nexplanon, the API Manufacturers by Location/Countries, 2015
• Nexplanon, Generic Players, 2015

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 化粧品用保存料の世界市場2016
    The Global Cosmetic Preservative Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Cosmetic Preservative industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain …
  • 世界トップ1000のPrefabricated Metal Building and Component製造企業データ:企業名、財務、経営陣、連絡先
    This company database offers valuable information on top 1000 prefabricated metal building and component producers in the world which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key company informati …
  • カナダの取引信用保険市場
    Trade Credit Insurance in Canada is a report about the market for trade credit cover in Canada. In addition to documenting the development of the market value from 2009 to 2013, the report also divides it for the most recent year between four key segments: between small companies with an annual turn …
  • 揚琴(チャイニーズダルシマー)の世界市場:販売動向2018
    This report studies the global Chinese Hammered Dulcimers market status and forecast, categorizes the global Chinese Hammered Dulcimers market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast …
  • ROG – Basel Antibody-Drug Conjugate Production Facility – Switzerland:建設プロジェクト概要
    World Market Intelligence's "ROG – Basel Antibody-Drug Conjugate Production Facility – Switzerland - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the ROG – Basel Antibody-Drug Conjugate Production Facility – Switzerlan …
  • マルトデキストリンの世界市場2014
    Maltodextrin (CAS 9050-36-6) Market Research Report 2014 aims at providing comprehensive data on Maltodextrin market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Maltodextrin description, covers its application areas, manufacturing methods, patents. I …
  • 化粧品包装の世界市場2017-2026
    According to Stratistics MRC, the Global Cosmetic Packaging market is accounted for $2277.39 million in 2017 and is expected to reach $3980.81 million by 2026 growing at a CAGR of 6.4%. Increasing demand for convenient packaging, growing focus toward grooming and personal appearance in the male cosm …
  • Sickle Cell Disease:パイプライン分析(ヘルスケア市場レポート)H1 2013
    Sickle Cell Disease – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sickle Cell Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Sickle Cell Disease, complete with late …
  • 中東の不動産市場
    The market research report titled “Middle East Real Estate Market Outlook to 2019 - Demand for Destination Retail and Affordable Housing to Shape Future” provides an in-depth analysis of the Middle East real estate market. The report covers specific insights on the market size in terms of value, seg …
  • 世界の動物用麻酔薬蒸発器市場2017
    Veterinary Anesthesia Evaporators Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Uni …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DID2015API204 )"Nexplanon:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015" (英文:Nexplanon-API Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。